物质信息
ID:361725
名称和标识
别名
Ketanserin (+)-tartrate salt3-(2-[4-(4-Fluorobenzoyl)-1-piperidinyl]ethyl)-2,4(1H,3H)-quinazolinedione (+)-tartrate saltR 41468 (+)-tartrate salt
IUPAC标准名
(2R,3R)-2,3-dihydroxybutanedioic acid; 3-{2-[4-(4-fluorobenzoyl)piperidin-1-yl]ethyl}-1,2,3,4-tetrahydroquinazoline-2,4-dione
IUPAC传统名
L(+)-tartaric acid; ketanserin
化合物性质
产品相关信息
Empirical Formula (Hill Notation)
C22H22FN3O3 · C4H6O6
纯度
≥98.0% (TLC)
安全信息
GHS危险声明
H301
个人保护装置
Eyeshields, Faceshields, Gloves, type P2 (EN 143) respirator cartridges
GHS警示性声明
P301+P310
安全公开号
22-36/37/39-45
GHS警示词
Danger
欧盟危险性物质标志
有毒 (T)MSDS下载
RTECS编号
VA1411195
德国WGK号
3
联合国危险货物等级
6.1
GHS危险品标识
急性毒性（口服，皮肤接触，吸入），类别1,2,3
RID/ADR
UN 2811 6.1/PG 3
危险公开号
25
联合国危险货物编号
2811
联合国危险货物包装类别(PG)
3
描述信息
Biochem/physiol Actions
Selective 5-HT2 serotonin receptor antagonist. Ketanserin significantly reduces nicotine self-administration in rats, supporting an unexpected involvement of serotonin in nicotine addiction.1
Selective 5-HT2 serotonin receptor antagonist. Ketanserin significantly reduces nicotine self-administration in rats, supporting an unexpected involvement of serotonin in nicotine addiction.1
分子图谱
暂无数据
点击上传数据
参考文献
暂无数据
点击上传数据